A switch in mechanism of action prevents doxorubicin-mediated cardiac damage
Alison Cheong, Sean McGrath, Tina Robinson, Ruqaya Maliki, Alex Spurling, Peter Lock, Ada Rephaeli, Abraham Nudelman, Belinda S. Parker, Salvatore Pepe, Suzanne M. Cutts
Topics & Concepts
DoxorubicinPharmacologyCardiotoxicityTopoisomeraseCardioprotectionApoptosisMedicineAnthracyclineDNA damageChemistryCancer researchToxicityCancerChemotherapyInternal medicineBiochemistryBreast cancerDNAMyocardial infarctionChemotherapy-induced cardiotoxicity and mitigationCancer Treatment and PharmacologyLung Cancer Research Studies